Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Dr. Leyfman Discusses the Increased risk of COVID-19 and Cancer Patients

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Dr. Leyfman discusses three medications that he hopes will prove to help with COVID-19:

  • Molnupiravir (which is now authorized for emergency use)
  • Mesenchymal Stem Cells that may have the following properties:
    • Antiviral
    • Immunomodulatory
    • Regenerative
  • Zofin for long COVID-19
    • amniotic fluid-derived extracellular vesicle biologic

Dr. Leyfman brings a unique and young mind to important questions. Whether his picks turn out to be the correct answers or not, he brings a fresh perspective. Please enjoy our video.

Brian Koffman MDCM (retired) MS Ed (he, him, his)
Co-Founder, Executive VP, and Chief Medical Officer
CLL Society, Inc.

CLL Society - COVID-19

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.